| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $10,575,910 | -55,037 | -79% | $192.16 | 14,968 | 02 Sep 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $1,384,334 | -7,185 | -48% | $192.67 | 7,783 | 03 Sep 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.00 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.88 to $193.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |